Variant report
Variant | nsv963935 |
---|---|
Chromosome Location | chr2:167863774-167877239 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:167859522..167861996-chr2:167862862..167865085,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16852863 | chr2:167875206-167875207 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs189104946 | chr2:167875240-167875241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368850307 | chr2:167875278-167875279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559613361 | chr2:167875281-167875282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs111618362 | chr2:167875302-167875303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528530523 | chr2:167875307-167875308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs367974372 | chr2:167875322-167875323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180999562 | chr2:167875327-167875328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535904000 | chr2:167875333-167875334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369787357 | chr2:167875366-167875367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184694016 | chr2:167875387-167875388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373271930 | chr2:167875411-167875412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569892130 | chr2:167875425-167875426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538458735 | chr2:167875434-167875435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs151322181 | chr2:167875442-167875443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189325884 | chr2:167875451-167875452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372242692 | chr2:167875455-167875456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534693927 | chr2:167875457-167875458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115962017 | chr2:167875460-167875461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574473021 | chr2:167875482-167875483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543363670 | chr2:167875577-167875578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs16852864 | chr2:167875589-167875590 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs10188981 | chr2:167875603-167875604 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs546095482 | chr2:167875681-167875682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181383082 | chr2:167875738-167875739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140586686 | chr2:167875744-167875745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145820696 | chr2:167875751-167875752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561788184 | chr2:167875787-167875788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530825047 | chr2:167875828-167875829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550905497 | chr2:167875852-167875853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539094315 | chr2:167875856-167875857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186808369 | chr2:167875888-167875889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138376417 | chr2:167875899-167875900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140915703 | chr2:167875926-167875927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552124331 | chr2:167875953-167875954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114754072 | chr2:167875956-167875957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534748521 | chr2:167875959-167875960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372656320 | chr2:167875975-167875976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554712868 | chr2:167875984-167875985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549113284 | chr2:167876064-167876065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550941425 | chr2:167876091-167876092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568113211 | chr2:167876166-167876167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Autism | 18414403 | CNVD |
Developmental delay | 21147756 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neonatal seizures | 20384724 | CNVD |
severe myoclonic epilepsy of infancy | 18294202 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:167875200-167875600 | Enhancers | Fetal Thymus | thymus |
2 | chr2:167875200-167875800 | Enhancers | Primary T cells from cord blood | blood |
3 | chr2:167875400-167876200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |